Dow Jones

38,686.32

1.51%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

ONCE

Onconetix (ONCE)

Onconetix Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ONCE

1 2 3 4 5 6 7 8 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
26/04/2024	16:26	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ONCE	Onconetix Inc
11/04/2024	15:43	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ONCE	Onconetix Inc
08/04/2024	15:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ONCE	Onconetix Inc
01/04/2024	15:05	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:ONCE	Onconetix Inc
13/03/2024	15:59	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ONCE	Onconetix Inc
16/02/2024	15:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ONCE	Onconetix Inc
14/02/2024	16:06	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ONCE	Onconetix Inc
14/02/2024	16:04	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ONCE	Onconetix Inc
01/02/2024	16:09	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ONCE	Onconetix Inc
14/02/2020	15:12	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ONCE	Onconetix Inc
27/12/2019	13:12	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:ONCE	Onconetix Inc
18/12/2019	16:00	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ONCE	Onconetix Inc
17/12/2019	15:55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ONCE	Onconetix Inc
17/12/2019	15:28	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ONCE	Onconetix Inc
17/12/2019	08:20	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:ONCE	Onconetix Inc
17/12/2019	08:13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ONCE	Onconetix Inc
17/12/2019	07:55	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ONCE	Onconetix Inc
17/12/2019	07:48	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:ONCE	Onconetix Inc
13/12/2019	14:51	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:ONCE	Onconetix Inc
09/12/2019	01:16	Dow Jones News	Roche Extends Tender Offer for Spark Therapeutics	NASDAQ:ONCE	Onconetix Inc
07/11/2019	15:37	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ONCE	Onconetix Inc
29/10/2019	10:17	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ONCE	Onconetix Inc
25/10/2019	08:54	GlobeNewswire Inc.	Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology Product	NASDAQ:ONCE	Onconetix Inc
22/10/2019	01:46	Dow Jones News	U.K.'s Competition Watchdog Opens Probe into Roche Takeover of Spark Therapeutics	NASDAQ:ONCE	Onconetix Inc
25/09/2019	01:54	Dow Jones News	U.K. Regulator to Probe Roche's Acquisition of Spark Therapeutics	NASDAQ:ONCE	Onconetix Inc
18/09/2019	06:30	GlobeNewswire Inc.	Paralympic Skier Danelle Umstead Teams Up with Spark Therapeutics to Help People Living with Inherited Retinal Diseases (IRDs...	NASDAQ:ONCE	Onconetix Inc
27/08/2019	08:18	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ONCE	Onconetix Inc
27/08/2019	06:30	GlobeNewswire Inc.	Spark Therapeutics Announces Change of Location for Annual Meeting of Stockholders	NASDAQ:ONCE	Onconetix Inc
31/07/2019	00:48	Dow Jones News	Roche Extends Offer Period for Spark Therapeutics	NASDAQ:ONCE	Onconetix Inc
22/07/2019	15:20	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ONCE	Onconetix Inc